Jori Fleisher is a Neurology physician. OpenAlex indexes 98 publications with 1,401 citations (h-index 21); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
240 E 38th St
20th Floor
New York, NY 100162708
Telephone
212-263-4838Registry record last updated 2 Mar 2016.
Clinical trials
- PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Sponsor: Rush University Medical Center
- Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Sponsor: Rush University Medical Center
- Kick Out Parkinson's Disease 2
Sponsor: Rush University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
91.8%Aromatic Amino Acid Decarboxylation Inhibitor36.1%Carbidopa-Levodopa68%Carbidopa-Levodopa Er24%Rytary8%Part D<11 patientsCholinesterase Inhibitor12.3%Donepezil Hcl84%Rivastigmine16%Part D≥36 patients+ 13 more classes in this area
Cardiovascular
4.4%Adrenergic and dopaminergic agents2.8%Droxidopa100%Part D<11 patientsalpha-Adrenergic Agonist1.5%Midodrine Hcl100%Part D<11 patientsHormonal (systemic)
3.9%Mineralocorticoids3.9%Fludrocortisone Acetate100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Loneliness in Parkinson's disease: Subjective experience overshadows objective motor impairment
Parkinsonism & Related Disorders
2025 - Diagnostic work up when suspecting early onset Parkinson disease (EOPD). Recommendations from the MDS EOPD study group
Parkinsonism & Related Disorders
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”